Michael Klien News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ZURICH, April 2 - UBS on Tuesday said it was launching a new share buyback programme of up to $2 billion, with up to half being completed in 2024. ...

(Bloomberg) -- Runaway demand for Novo Nordisk A/S’s diabetes and weight-loss drugs has propelled the Danish drugmaker into a class all its own atop Europe’s pharmaceutical sector — and the Stoxx Europe 600 Index — so achieving its 2023 targets should be a shoo-in when it reports next week.Most Read from BloombergPutin Sends US Signal on Ukraine Talks, Seeing War AdvantageUS Extends Lead Over China in Race for World’s Biggest EconomyTesla Sinks After Warning About ‘Notably Lower’ Growth RateJPMo

(Bloomberg) -- Julius Baer Group Ltd. slumped the most in more than three years as a sudden jump in bad loan provisions revived concerns about the Swiss bank’s exposure to the crumbling property empire of Austrian tycoon Rene Benko.Most Read from BloombergThe Doomed Mission Behind Sam Altman's Shock Ouster From OpenAIMicrosoft Ends Weekend of OpenAI Drama With Coup of Its OwnOpenAI Leaders' Efforts to Bring Back Altman Reach Impasse Over Board RoleOpenAI’s Murati Aims to Re-Hire Altman, Brockman

Swiss private bank Julius Baer announced an overhaul of its executive board on Monday, with executives from UBS among the new appointments. The changes, which include ......

Swiss private bank Julius Baer announced an overhaul of its executive board on Monday, with executives from UBS among the new appointments....